+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report by Products (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT-D, CRT-P)), by Region, and Segment Forecasts, 2022-2030

  • ID: 4479740
  • Report
  • January 2022
  • Region: Global
  • 150 Pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott
  • BIOTRONIK
  • Koninklijke Philips N.V.
  • LivaNova Plc
  • Medtronic
  • Progetti Srl
The global cardiac rhythm management devices market size is anticipated to reach USD 31.9 billion by 2030. The market is expected to expand at a lucrative CAGR of 6.5% from 2022 to 2030. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.



Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020. The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices. Innovation with regards to implantable devices includes products, such as subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment.

Therefore, the market is anticipated to grow because of technological advancements and product innovations. Revolutionary technological signs of progress are rapidly transforming the market. These expansions are producing lucrative potentials. An increase in R&D expenditure and new product launches by leading firms further fueled the growth. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, hence expanding its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Such factors boost market growth. Key market players account for a significant share of the market owing to their extensive product offerings.

Cardiac Rhythm Management Devices Market Report Highlights

  • The market was valued at USD 18.1 million in 2021 and is expected to expand at a CAGR of 6.5% during the forecast period
  • By product, defibrillators dominated the market with a share of over 43.6% in 2021 due to their high adoption globally
  • The ICD segment was the largest in defibrillators as of 2021, accounting for more than 60% of the revenue share, owing to its better patient outcome
  • In the external defibrillator segment, the automatic external defibrillator segment held the highest revenue share owing to associated benefits, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat
  • In 2021, North America held the dominant share of the market owing to the rising prevalence of cardiovascular diseases and high adoption of CRM devices
  • Asia Pacific region is expected to show lucrative growth over the forecast period owing to the presence of emerging countries such as China and India


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Cardiac Rhythm Management Devices Market

What is the estimated value of the Global Cardiac Rhythm Management Devices Market?

The Global Cardiac Rhythm Management Devices Market was estimated to be valued at $19.1 Billion in 2022.

What is the growth rate of the Global Cardiac Rhythm Management Devices Market?

The growth rate of the Global Cardiac Rhythm Management Devices Market is 6.6%, with an estimated value of $31.9 Billion by 2030.

What is the forecasted size of the Global Cardiac Rhythm Management Devices Market?

The Global Cardiac Rhythm Management Devices Market is estimated to be worth $31.9 Billion by 2030.

Who are the key companies in the Global Cardiac Rhythm Management Devices Market?

Key companies in the Global Cardiac Rhythm Management Devices Market include LivaNova Plc, Physio, Control, Inc. (Stryker), Schiller, Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V. and BIOTRONIK.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • BIOTRONIK
  • Koninklijke Philips N.V.
  • LivaNova Plc
  • Medtronic
  • Progetti Srl

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in the Asia Pacific
1.3.5.4 Data for primary interviews in the Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Cardiac rhythm management devices Market Outlook, 2017-2030 (USD Million)
2.2 Segment Outlook
Chapter 3 Cardiac Rhythm Management Devices Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.3.1 List of Regulatory Bodies
3.4 Cardiac rhythm management devices: Market Dynamics
3.4.1 Market Driver Analysis
3.4.2 Market Restraint Analysis
3.4.3 Market Opportunity Analysis
3.4.4 Market Challenge Analysis
3.5 Cardiac rhythm management devices Market Analysis Tools: Porter's
3.5.1 Supplier Power
3.5.2 Buyer Power
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 SWOT By PEST Analysis
3.6.1 Political & Legal Landscape
3.6.2 Economic Landscape
3.6.3 Technology Landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Product Launch
3.7.3 Expansion
3.7.4 Partnership & Collaborations
3.7.5 Market Entry Strategies
3.8 Disease Prevalence Analysis
Chapter 4 Cardiac Rhythm Management Devices Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Public Companies
4.2.1 Company Market Position Analysis
4.2.2 Competitive Dashboard Analysis
4.3 Detailed List of Market Players
Chapter 5 Impact of COVID-19
5.1 COVID-19 Impact Analysis
5.2 Impact on Market Players
5.3 Opportunity Analysis
Chapter 6 Cardiac Rhythm Management Devices Market: Product Estimates & Trend Analysis
6.1 Definition and Scope
6.2 Product Type Market Share Analysis, 2021 & 2030
6.3 Global CRM Devices Market, by Product, 2017 to 2030
6.4 Market Size & Forecasts and Trend Analysis, 2017 to 2030
6.4.1 Pacemaker
6.4.1.1 Pacemaker, 2017-2030 (USD Million)
6.4.1.2 ImplanTable Pacemaker
6.4.1.2.1 ImplanTable Pacemaker, 2017-2030 (USD Million)
6.4.1.3 External Pacemaker
6.4.1.3.1 External Pacemaker, 2017-2030 (USD Million)
6.4.2 Defibrillators
6.4.2.1 Defibrillators, 2017-2030 (USD Million)
6.4.2.2 ICDs
6.4.2.2.1 ICDs, 2017-2030 (USD Million)
6.4.2.2.2 S-ICDs
6.4.2.2.2.1 S-ICDs, 2017-2030 (USD Million)
6.4.2.2.3 T-ICD
6.4.2.2.3.1 T-ICD, 2017-2030 (USD Million)
6.4.2.3 External Defibrillators
6.4.2.3.1 External Defibrillators, 2017-2030 (USD Million)
6.4.2.3.2 Manual External Defibrillators
6.4.2.3.2.1 Manual External Defibrillators, 2017-2030 (USD Million)
6.4.2.3.3 Automatic External Defibrillators (AED)
6.4.2.3.3.1 Automatic External Defibrillators, 2017-2030 (USD Million)
6.4.2.3.4 Wearable Cardioverter Defibrillators (WCD)
6.4.2.3.4.1 Wearable Cardioverter Defibrillators, 2017-2030 (USD Million)
6.4.3 CRT
6.4.3.1 CRT, 2017-2030 (USD Million)
6.4.3.2 CRT pacemaker
6.4.3.2.1 CRT pacemaker, 2017-2030 (USD Million)
6.4.3.3 CRT-Defibrillators
6.4.3.3.1 CRT-defibrillators, 2017-2030 (USD Million)
Chapter 7 Cardiac Rhythm Management Devices Market: Regional Estimates & Trend Analysis, by Product
7.1 Definition & Scope
7.2 Regional Market Snapshot
7.3 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
7.4 North America
7.4.1 North America market estimates and forecast, by country, 2017-2030 (USD Million)
7.4.2 U.S.
7.4.2.1 U.S. CRM Devices market, 2017-2030 (USD Million)
7.4.3 Canada
7.4.3.1 Canada CRM Devices market, 2017-2030 (USD Million)
7.5 Europe
7.5.1 Europe CRM devices market, by country, 2017-2030 (USD Million)
7.5.2 U.K.
7.5.2.1 U.K. CRM Devices market, 2017-2030 (USD Million)
7.5.3 Germany
7.5.3.1 Germany CRM Devices Market, 2017-2030 (USD Million)
7.5.4 France
7.5.4.1 France CRM Devices market, 2017-2030 (USD Million)
7.5.5 Italy
7.5.5.1 Italy CRM Devices market, 2017-2030 (USD Million)
7.5.6 Spain
7.5.6.1 Spain CRM Devices market, 2017-2030 (USD Million)
7.6 Asia Pacific
7.6.1 Asia Pacific CRM devices market, by country, 2017-2030 (USD Million)
7.6.2 Japan
7.6.2.1 Japan CRM Devices market, 2017-2030 (USD Million)
7.6.3 China
7.6.3.1 China CRM Devices market, 2017-2030 (USD Million)
7.6.4 Australia
7.6.4.1 Australia CRM Devices market, 2017-2030 (USD Million)
7.6.5 India
7.6.5.1 India CRM Devices market, 2017-2030 (USD Million)
7.7 Latin America
7.7.1 Latin America CRM devices market, by country, 2017-2030 (USD Million)
7.7.2 Brazil
7.7.2.1 Brazil CRM Devices market, 2017-2030 (USD Million)
7.7.3 Mexico
7.7.3.1 Mexico CRM Devices market, 2017-2030 (USD Million)
7.8 MEA
7.8.1 MEA CRM devices market, by country, 2017-2030 (USD Million)
7.8.2 South Africa
7.8.2.1 South Africa CRM Devices market, 2017-2030 (USD Million)
7.8.3 Saudi Arabia
7.8.3.1 Saudi Arabia CRM Devices market, 2017-2030 (USD Million)
Chapter 8 Company Profiles
8.1 LivaNova Plc
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Physio-Control, Inc. (Stryker)
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 Schiller
8.3.1 Company Overview
8.3.2 Product Benchmarking
8.3.3 Strategic Initiatives
8.4 Medtronic
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Abbott
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Boston Scientific Corporation
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Zoll Medical Corporation
8.8.1 Company Overview
8.8.2 Product Benchmarking
8.8.3 Strategic Initiatives
8.9 BIOTRONIK
8.9.1 Company Overview
8.9.2 Product Benchmarking
8.9.3 Strategic Initiatives
8.10 Progetti Srl
8.10.1 Company Overview
8.10.2 Product Benchmarking
8.10.3 Strategic Initiatives
List of Tables
Table 1 Primary interview details: North America
Table 2 Primary interview details: Europe
Table 3 Primary interview details: Asia Pacific
Table 4 Primary interview details: Latin America
Table 5 Primary interview details: Middle East and Africa
Table 6 List of secondary sources
Table 7 Technological trends in CRM Devices
Table 8 Recently approved AEDs
Table 9 North America CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 10 North America pacemaker market, by product, 2017-2030 (USD Million)
Table 11 North America defibrillator market, by product, 2017-2030 (USD Million)
Table 12 North America Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 13 U.S. CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 14 U.S. pacemaker market, by product, 2017-2030 (USD Million)
Table 15 U.S. defibrillator market, by product, 2017-2030 (USD Million)
Table 16 U.S. Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 17 Canada CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 18 Canada pacemaker market, by product, 2017-2030 (USD Million)
Table 19 Canada defibrillator market, by product, 2017-2030 (USD Million)
Table 20 Canada Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 21 Europe CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 22 Europe pacemaker market, by product, 2017-2030 (USD Million)
Table 23 Europe defibrillator market, by product, 2017-2030 (USD Million)
Table 24 Europe Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 25 U.K. CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 26 U.K. pacemaker market, by product, 2017-2030 (USD Million)
Table 27 U.K. defibrillator market, by product, 2017-2030 (USD Million)
Table 28 U.K. Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 29 Germany CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 30 Germany pacemaker market, by product, 2017-2030 (USD Million)
Table 31 Germany defibrillator market, by product, 2017-2030 (USD Million)
Table 32 Germany Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 33 France CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 34 France pacemaker market, by product, 2017-2030 (USD Million)
Table 35 France defibrillator market, by product, 2017-2030 (USD Million)
Table 36 France Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 37 Italy CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 38 Italy pacemaker market, by product, 2017-2030 (USD Million)
Table 39 Italy defibrillator market, by product, 2017-2030 (USD Million)
Table 40 Italy Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 41 Spain CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 42 Spain pacemaker market, by product, 2017-2030 (USD Million)
Table 43 Spain defibrillator market, by product, 2017-2030 (USD Million)
Table 44 Spain Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 45 Asia Pacific CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 46 Asia Pacific pacemaker market, by product, 2017-2030 (USD Million)
Table 47 Asia Pacific defibrillator market, by product, 2017-2030 (USD Million)
Table 48 Asia Pacific Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 49 Japan CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 50 Japan pacemaker market, by product, 2017-2030 (USD Million)
Table 51 Japan defibrillator market, by product, 2017-2030 (USD Million)
Table 52 Japan Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 53 China CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 54 China pacemaker market, by product, 2017-2030 (USD Million)
Table 55 China defibrillator market, by product, 2017-2030 (USD Million)
Table 56 China Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 57 Australia CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 58 Australia pacemaker market, by product, 2017-2030 (USD Million)
Table 59 Australia defibrillator market, by product, 2017-2030 (USD Million)
Table 60 Australia Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 61 India CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 62 India pacemaker market, by product, 2017-2030 (USD Million)
Table 63 India defibrillator market, by product, 2017-2030 (USD Million)
Table 64 India Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 65 Latin America CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 66 Latin America pacemaker market, by product, 2017-2030 (USD Million)
Table 67 Latin America defibrillator market, by product, 2017-2030 (USD Million)
Table 68 Latin America Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 69 Brazil CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 70 Brazil pacemaker market, by product, 2017-2030 (USD Million)
Table 71 Brazil defibrillator market, by product, 2017-2030 (USD Million)
Table 72 Brazil Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 73 Mexico CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 74 Mexico pacemaker market, by product, 2017-2030 (USD Million)
Table 75 Mexico defibrillator market, by product, 2017-2030 (USD Million)
Table 76 Mexico Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 77 MEA CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 78 MEA pacemaker market, by product, 2017-2030 (USD Million)
Table 79 MEA defibrillator market, by product, 2017-2030 (USD Million)
Table 80 MEA Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 81 South Africa CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 82 South Africa pacemaker market, by product, 2017-2030 (USD Million)
Table 83 South Africa defibrillator market, by product, 2017-2030 (USD Million)
Table 84 South Africa Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
Table 85 Saudi Arabia CRM devices market revenues, by product type, 2017-2030 (Revenues USD Million)
Table 86 Saudi Arabia pacemaker market, by product, 2017-2030 (USD Million)
Table 87 Saudi Arabia defibrillator market, by product, 2017-2030 (USD Million)
Table 88 Saudi Arabia Cardiac Resynchronization Therapy (CRT) market, by products, 2017-2030 (USD Million)
List of Charts
Fig. 1 CRM Devices Segmentation and Scope
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Primary interviews in North America
Fig. 6 Primary interviews in Europe
Fig. 7 Primary interviews in Asia Pacific
Fig. 8 Primary interviews in Latin America
Fig. 9 Primary interviews in Middle East and Africa
Fig. 10 Market research approaches
Fig. 11 Value-chain-based sizing & forecasting
Fig. 12 QFD modeling for market share assessment
Fig. 13 Market formulation & validation
Fig. 14 Commodity flow analysis
Fig. 15 Volume price analysis
Fig. 16 Market outlook (2021)
Fig. 17 Segment outlook
Fig. 18 Market driver relevance analysis (Current & future impact)
Fig. 19 CVD prevalence in the U.S. (%)
Fig. 20 CVD prevalence in the U.S. by cardiac diseases (percentage, %)
Fig. 21 Geriatric population (million)
Fig. 22 Market restraint relevance analysis (Current & future impact)
Fig. 23 Porter’s five forces analysis
Fig. 24 PESTLE analysis
Fig. 25 Strategy mapping
Fig. 26 CRM Devices market: Product movement analysis
Fig. 27 CRM Devices market product outlook: Key takeaways
Fig. 28 Pacemaker, 2017-2030 (USD million)
Fig. 29 ImplanTable pacemaker, 2017-2030 (USD million)
Fig. 30 External pacemaker, 2017-2030 (USD million)
Fig. 31 Defibrillators, 2017-2030 (USD million)
Fig. 32 ICDs, 2017-2030 (USD million)
Fig. 33 S-ICD, 2017-2030 (USD million)
Fig. 34 T-ICD, 2017-2030 (USD million)
Fig. 35 External defibrillators, 2017-2030 (USD million)
Fig. 36 Manual external defibrillators, 2017-2030 (USD million)
Fig. 37 Automatic external defibrillators, 2017-2030 (USD million)
Fig. 38 Wearable cardioverter defibrillators, 2017-2030 (USD million)
Fig. 39 CRT, 2017-2030 (USD million)
Fig. 40 CRT pacemaker, 2017-2030 (USD million)
Fig. 41 CRT defibrillators, 2017-2030 (USD million)
Fig. 42 CRM Devices market: Regional movement analysis
Fig. 43 Regional marketplace: Key takeaways
Fig. 44 North America CRM Devices market, by country, 2017-2030 (USD Million)
Fig. 45 U.S. CRM Devices market, 2017-2030 (USD Million)
Fig. 46 Canada CRM Devices market, 2017-2030 (USD Million)
Fig. 47 Europe CRM Devices market, by country, 2017-2030 (USD Million)
Fig. 48 U.K. CRM Devices market, 2017-2030 (USD Million)
Fig. 49 Germany CRM Devices market, 2017-2030 (USD Million)
Fig. 50 France CRM Devices market, 2017-2030 (USD Million)
Fig. 51 Italy CRM Devices market, 2017-2030 (USD Million)
Fig. 52 Spain CRM Devices market, 2017-2030 (USD Million)
Fig. 53 Asia Pacific CRM Devices market, by country, 2017-2030 (USD Million)
Fig. 54 Japan CRM Devices market, 2017-2030 (USD Million)
Fig. 55 China CRM Devices market, 2017-2030 (USD Million)
Fig. 56 Australia CRM Devices market, 2017-2030 (USD Million)
Fig. 57 India CRM Devices market, 2017-2030 (USD Million)
Fig. 58 Latin America CRM Devices market, by country, 2017-2030 (USD Million)
Fig. 59 Brazil CRM Devices market, 2017-2030 (USD Million)
Fig. 60 Mexico CRM Devices market, 2017-2030 (USD Million)
Fig. 61 MEA CRM Devices market, by country, 2017-2030 (USD Million)
Fig. 62 South Africa CRM Devices market, 2017-2030 (USD Million)
Fig. 63 Saudi Arabia CRM Devices market, 2017-2030 (USD Million)
Note: Product cover images may vary from those shown
  • LivaNova Plc
  • Physio-Control, Inc. (Stryker)
  • Schiller
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Zoll Medical Corporation
  • BIOTRONIK
  • Progetti Srl
Note: Product cover images may vary from those shown

Loading
LOADING...